Ocugen, Inc. (OCGN)
1.21
+0.01
(+0.83%)
USD |
NASDAQ |
Dec 09, 16:00
1.19
-0.02
(-1.65%)
After-Hours: 20:00
Ocugen EPS Diluted (Quarterly): -0.066 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Belite Bio, Inc. | -0.6529 |
| MannKind Corp. | 0.0256 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| CorMedix, Inc. | 1.259 |
| Verastem, Inc. | -1.347 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.05M |
| Revenue (Quarterly) | 1.752M |
| Total Expenses (Quarterly) | 21.80M |
| Enterprise Value | 378.31M |
| Gross Profit Margin (Quarterly) | 45.78% |
| Profit Margin (Quarterly) | -1.14K% |
| Earnings Yield | -17.92% |
| Normalized Earnings Yield | -17.92 |